Wakamoto Pharmaceutical Co.,Ltd. (4512.T) JPX

Currency In JPY

AD

Valuation

Market Cap12.18B
Enterprise Value10.58B
P/E Ratio39.08
PEG Ratio-0.05
Price/Sales Ratio0.9
Price/Book Ratio0.74
Enterprise/Revenue0.73
Enterprise/EBITDA10.38

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.02
Operating Margin0.03
AD

Management Effectiveness

Return On Assets0.01
Return On Equity0.02

Income Statement

Revenue9.91B
Revenue/Share285.43
Gross Profit4.73B
EBITDA701.22M
Net Income227.22M
Diluted EPS6.55

Balance Sheet

Total Cash2.01B
Total Cash/Share57.8
Total Debt400M
Total Debt/Equity0.03
Current Ratio3.48
Book Value Per Share345.99

Price History

52-Week Change-16.34
52-Week High380
52-Week Low240
Moving Average 50 Days307.38
Moving Average 200 Days305.95

Statistics

Average Volume92,603
Shares Outstanding34.71M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate3.5
Trailing Annual Dividend Yield1.37
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A
AD